Shares of Moderna have tumbled 40% this year, Ark’s Genomic Revolution ETF nearly 50%.
Category: healthcare
Can Reinforcement Learning Help Fix The Mental Health Crisis?
Stefano Goria is Co-Founder and Chief Technical Officer (CTO) of Thymia, a company aiming to make mental health assessments faster and more accurate through an approach that combines video games based on neuropsychology with analyses of facial microexp…
White House Unveils Covid Vaccination Plan For Children Under 5, Orders 10 Million Doses
The FDA and CDC are set to decide next week on authorizing vaccines for children under the age of five.
InnovationRx: Healthcare VC Outlook; Plus, Covid And Cognitive Function
InnovationRx is your weekly digest of healthcare news. Sign up!
Aetna Cancels In-Network Contract With Mental Health Startup Cerebral
The $4.8 billion startup is being investigated by the Department of Justice over its controlled dangerous substances prescribing practices.
How LifeScan Invents And Develops New Products Using Open Innovation
Leading companies are seeking out partners to fulfill their innovative goals more readily and transform their businesses with new technologies and services.
A Two-Year Reprieve For Medicare Insolvency Sounds Like Good News. But It Isn’t
The Medicare trustees’ new estimate that the program’s Part A Hospital Insurance (HI) Trust fund will remain solvent for an extra two years—to 2028—sounds like good news. But before you break out the champagne, keep a few things in mind:
UnitedHealth Group’s Foundation Commits $100 Million To Health Equity And Diverse Workforce
UnitedHealth Group is committing $100 million over a decade to advance health equity.
Mental Health In Cybersecurity—51% Of Workers Take Meds, Me Included
The cybersecurity industry seems prone to mental health issues – here’s how to get help for anxiety, burnout, depression and stress.
Moderna’s Booster Shot Targeting Omicron And Original Strain Could Be Available Late Summer After Promising Trials
Moderna chief executive Stéphane Bancel said early data suggests the bivalent shot could provide more long-lasting protection against variants of concern than the company’s original formula alone.
